Explore our comprehensive portfolio that addresses the complete care continuum for many of the world’s most threatening diseases. 

Discover the stories of pioneers pushing the boundaries of what’s possible in healthcare to help improve people’s lives around the world.

Patient-centered innovation has been and always will be at the core of our company. Dive deeper into our fascinating technologies.

We pioneer breakthroughs in healthcare. For everyone. Everywhere. Sustainably. Learn more about our purpose, our innovation leadership, our culture, and our strategy.

  1. Home

  2. Press center
  3. Press releases
  4. Siemens Healthineers Supervisory Board extends the mandates of Bernd Montag and Jochen Schmitz
Press release

Siemens Healthineers Supervisory Board extends the mandates of Bernd Montag and Jochen Schmitz

Published on May 5, 2020

In its meeting on today’s date, the Supervisory Board of Siemens Healthineers AG prematurely and unanimously extended the terms of office of CEO Dr. Bernd Montag (51) and CFO Dr. Jochen Schmitz (54) by five years. The two managers will now hold these positions until the end of February 2026.

"Bernd Montag and Jochen Schmitz have led the company very successfully and decisively shaped its progress over the past few years. They set the right course with successful implementation of the first phase of Strategy 2025. In the coming years, the company will strive to reach the next level of profitable growth and sustainably extend the company’s leading market position,“ said Prof. Dr. Ralf P. Thomas, Chairman of the Supervisory Board of Siemens Healthineers AG.

Management

 

Bernd Montag

Chief Executive Officer, Siemens Healthineers  

Jochen Schmitz

Chief Financial Officer, Siemens Healthineers

Download this press release(pdf, 124.97 KB)

Siemens Healthineers 2020

Siemens Healthineers AG (listed in Frankfurt, Germany: SHL) is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. In fiscal 2020, which ended on September 30, 2020, Siemens Healthineers, which has approximately 54,000 employees worldwide, generated revenue of €14.5 billion and adjusted EBIT of €2.2 billion.